Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial dynamics protein MID51 (MIEF1) is an integral protein of the mitochondrial outer membrane, vertebrate-specific, and a key regulator of mitochondrial morphology. MIEF1 recruits cytosolic dynamin-related protein 1 (Drp1) to the mitochondrial surface and binds both Drp1 and hFis1, coordinating and fine-tuning the balance between mitochondrial fission and fusion. Overexpression of MIEF1 inhibits Drp1-mediated mitochondrial fission by sequestering Drp1 in an inactive state, leading to elongated (fused) mitochondria, while depletion results in excessive mitochondrial fragmentation. This regulation is critical for normal organelle function and cellular health, and dominant mutations in MIEF1 have been linked to neurodegenerative diseases such as optic neuropathy[1][2][3][4][5].
Drp1 (dynamin-related protein 1) recruitment and inhibition—MIEF1 binds and recruits Drp1 to mitochondria but suppresses Drp1’s GTPase activity and impedes mitochondrial fission, thus promoting fusion[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial dynamics protein MID51 (MIEF1).